206 related articles for article (PubMed ID: 22654525)
41. A prospective study of anti-mullerian hormone and other ovarian and adrenal hormones in adult female acne.
Bansal P; Sardana K; Arora P; Khurana A; Garga UC; Sharma L
Dermatol Ther; 2020 Nov; 33(6):e13974. PubMed ID: 33185003
[TBL] [Abstract][Full Text] [Related]
42. Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity.
Baillargeon JP; Carpentier A
Fertil Steril; 2007 Oct; 88(4):886-93. PubMed ID: 17559844
[TBL] [Abstract][Full Text] [Related]
43. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome.
Köninger A; Sauter L; Edimiris P; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B
Hum Reprod; 2014 Mar; 29(3):518-24. PubMed ID: 24419495
[TBL] [Abstract][Full Text] [Related]
44. Serum visfatin, vascular endothelial growth factor and matrix metalloproteinase-9 in women with polycystic ovary syndrome.
Dambala K; Vavilis D; Bili E; Goulis DG; Tarlatzis BC
Gynecol Endocrinol; 2017 Jul; 33(7):529-533. PubMed ID: 28300464
[TBL] [Abstract][Full Text] [Related]
45. Exploration of the role of anti-Mullerian hormone and LH/FSH ratio in diagnosis of polycystic ovary syndrome.
Le MT; Le VNS; Le DD; Nguyen VQH; Chen C; Cao NT
Clin Endocrinol (Oxf); 2019 Apr; 90(4):579-585. PubMed ID: 30636332
[TBL] [Abstract][Full Text] [Related]
46. Serum leptin level in women with polycystic ovary syndrome: correlation with adiposity, insulin, and circulating testosterone.
Chakrabarti J
Ann Med Health Sci Res; 2013 Apr; 3(2):191-6. PubMed ID: 23919188
[TBL] [Abstract][Full Text] [Related]
47. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
Pehlivanov B; Mitkov M
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
[TBL] [Abstract][Full Text] [Related]
48. Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease.
Zhang J; Hu J; Zhang C; Jiao Y; Kong X; Wang W
Exp Ther Med; 2018 May; 15(5):4259-4264. PubMed ID: 29725371
[TBL] [Abstract][Full Text] [Related]
49. Influence of Insulin on LH, Testosterone and SHBG in various PCOS Categories based on the Mode of Secretion of LH in relation to FSH Levels.
Malini NA; Roy GK
Acta Endocrinol (Buchar); 2021; 17(3):313-318. PubMed ID: 35342460
[TBL] [Abstract][Full Text] [Related]
50. Study of carbohydrate metabolism indices and adipocytokine profile and their relationship with androgens in polycystic ovary syndrome after menopause.
Markopoulos MC; Valsamakis G; Kouskouni E; Boutsiadis A; Papassotiriou I; Creatsas G; Mastorakos G
Eur J Endocrinol; 2013 Jan; 168(1):83-90. PubMed ID: 23076844
[TBL] [Abstract][Full Text] [Related]
51. [Plasma metastin in adolescent polycystic ovary syndrome.].
Chen XL; Mo YQ; Li L; Chen YX; Li Y; Zhang QX; Yang DZ
Zhonghua Fu Chan Ke Za Zhi; 2009 Oct; 44(10):745-9. PubMed ID: 20078960
[TBL] [Abstract][Full Text] [Related]
52. Serum leptin and ghrelin levels in women with polycystic ovary syndrome: correlation with anthropometric, metabolic, and endocrine parameters.
Houjeghani S; Pourghassem Gargari B; Farzadi L
Int J Fertil Steril; 2012 Jul; 6(2):117-26. PubMed ID: 25493169
[TBL] [Abstract][Full Text] [Related]
53. Reproductive Hormones and Anthropometry: A Follow-Up of PCOS and Controls From Perimenopause to Older Than 80 Years.
Forslund M; Schmidt J; Brännström M; Landin-Wilhelmsen K; Dahlgren E
J Clin Endocrinol Metab; 2021 Jan; 106(2):421-430. PubMed ID: 33205205
[TBL] [Abstract][Full Text] [Related]
54. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome.
Thierry van Dessel HJ; Lee PD; Faessen G; Fauser BC; Giudice LC
J Clin Endocrinol Metab; 1999 Sep; 84(9):3030-5. PubMed ID: 10487660
[TBL] [Abstract][Full Text] [Related]
55. Serum Fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome.
Enli Y; Fenkci SM; Fenkci V; Oztekin O
Gynecol Endocrinol; 2013 Dec; 29(12):1036-9. PubMed ID: 23961784
[TBL] [Abstract][Full Text] [Related]
56. Association between serum gonadotropin level and insulin resistance-related parameters in Korean women with polycystic ovary syndrome.
Park CH; Chun S
Obstet Gynecol Sci; 2016 Nov; 59(6):498-505. PubMed ID: 27896252
[TBL] [Abstract][Full Text] [Related]
57. Age and BMI Adjusted Comparison of Reproductive Hormones in PCOS.
Fakhoury H; Tamim H; Ferwana M; Siddiqui IA; Adham M; Tamimi W
J Family Med Prim Care; 2012 Jul; 1(2):132-6. PubMed ID: 24479022
[TBL] [Abstract][Full Text] [Related]
58. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A
Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
[TBL] [Abstract][Full Text] [Related]
59. Dehydroepiandrosterone sulfate/free androgen index ratio predicts a favorable metabolic profile in patients with polycystic ovary syndrome.
Nadir A; Temizkan S; Ozderya A; Temizkan O; Orbay E; Aydin K
Gynecol Endocrinol; 2019 Feb; 35(2):128-132. PubMed ID: 30324855
[TBL] [Abstract][Full Text] [Related]
60. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy.
Velazquez EM; Mendoza S; Hamer T; Sosa F; Glueck CJ
Metabolism; 1994 May; 43(5):647-54. PubMed ID: 8177055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
